Search for: "N.V. ORGANON" Results 1 - 20 of 21
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Mar 2007, 9:42 pm
By Donald Zuhn --- Schering-Plough Corporation announced on March 12th that its Board of Directors has approved the purchase of Organon BioSciences N.V. from Akzo Nobel N.V. for US $14.4 billion. [read post]
19 Jan 2008, 1:05 am
The FTC had announced a complaint last November challenging Schering Plough's proposed acquisition of healthcare products company Organon BioSciences for $14.4 billion from Dutch company Akzo-Nobel N.V. because the deal would allegedly harm competition in U.S. markets for the sale of three poultry vaccine in violation of the FTC Act § 5 and the Clayton Act § 7. [read post]
20 Apr 2010, 5:07 pm by Dr. Shezad Malik
The lawsuit complaints allege that the parties named as defendants, which includes Organon USA, Inc., Organon Pharmaceuticals USA, Inc., Organon International, Inc., Akzo Nobel NV, Organon Biosciences, N.V., and Schering-Plough Corporation, not only knew about the potential side effects associated with NUVARING®, but concealed those risks from the public, including the FDA during the approval process. [read post]
28 Feb 2011, 6:58 pm by Eric Schweibenz
., Inc. of Whitehouse Station, New Jersey Schering Plough Corporation of Kenilworth, New Jersey Organon USA, Inc. of Roseland, New Jersey N.V. [read post]
25 Mar 2011, 4:29 pm by Eric Schweibenz
., Inc. of Whitehouse Station, New Jersey Schering Plough Corporation of Kenilworth, New Jersey Organon USA, Inc. of Durham, North Carolina N.V. [read post]
25 Oct 2014, 6:43 am
" Judge Costa noted that “[t]he functionality doctrine is a significant hurdle for any party seeking to protect a flavor as a trademark,” citing the In re N.V. [read post]
24 Jan 2007, 6:15 pm
The non-citable decision, under the new Board policy, may be cited for whatever value it may have, but it is not binding precedent.In re Organon N.V., 79 USPQ2d 1639 (TTAB 2006) [precedential]. [read post]
1 Jul 2015, 11:16 am by Ron Coleman
Organon, for example, the Trademark Trial and Appeal Board (TTAB) denied a pharmaceutical company a trademark in the orange flavor of its pills on functionality grounds. 79 U.S.P.Q.2d 1639, at *6–13. [read post]